Utah Medical Products Inc
UTMD· Nasdaq
Released Jul 25, 2023, during market hours
10-Q filed Aug 11, 2023, 42 days after period end · 0001811884-23-000017
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $12.87M | $13.43M | $12.60M | $8.79M |
| Net Income | $4.20M | $4.10M | $3.43M | $1.31M |
| EPS Diluted |
Utah Medical Products Inc · CIK 706698 · Engraved from SEC EDGAR
| $1.15 |
| $1.12 |
| $0.94 |
| $0.36 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.